Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

NCT01214096 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped The same protocol has been launched in United States.

Conditions

Chronic Heart Failure

Interventions

DRUG: rhNRG-1
DRUG: rhNRG-1
DRUG: rhNRG-1
DRUG: placebo

Sponsor

Zensun Sci. & Tech. Co., Ltd.